Blood Cancer Journal - Table of Contents alert Volume 6 March 2016

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 6, March 2016 In this issue Original Articles Letters to the Editor Corrigendum Sign up for e-alerts Web feed Advertisement Blood Cancer Journal is an online-only, open access journal publishing high quality research on hematologic malignancies and related disorders.The journal has an Impact Factor of 3.467. Explore the benefits of submitting your next research article. Original Articles Top Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma M Binder, S V Rajkumar, R P Ketterling, A Dispenzieri, M Q Lacy, M A Gertz, F K Buadi, S R Hayman, Y L Hwa, S R Zeldenrust, J A Lust, S J Russell, N Leung, P Kapoor, R S Go, W I Gonsalves, R A Kyle and S K Kumar Blood Cancer J 2016 6: e401; 10.1038/bcj.2016.15 Abstract | Full Text Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial A Bühler, C-M Wendtner, T J Kipps, L Rassenti, G A M Fraser, A-S Michallet, P Hillmen, J Dürig, S A Gregory, M Kalaycio, T Aurran-Schleinitz, L Trentin, J G Gribben, A Chanan-Khan, B Purse, J Zhang, S De Bedout, J Mei, M Hallek and S Stilgenbauer Blood Cancer J 2016 6: e404; 10.1038/bcj.2016.9 Abstract | Full Text miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia A Navarro, S Pairet, A Álvarez-Larrán, A Pons, G Ferrer, R Longarón, C Fernández-Rodríguez, L Camacho, M Monzó, C Besses and B Bellosillo Blood Cancer J 2016 6: e406; 10.1038/bcj.2016.10 Abstract | Full Text Letters to the Editor Top Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014 M Laforet, N Jourde-Chiche, F Haddad, M Sallee, A M Stoppa, P Brunet, B Dussol, S Burtey and B Gondouin Blood Cancer J 2016 6: e409; 10.1038/bcj.2016.17 Full Text Loss of RUNX1 function results in enhanced granulocyte-colony-stimulating factor-mediated mobilization K Lam, A Muselman, R Du, M Yan, S Matsuura and D-E Zhang Blood Cancer J 2016 6: e407; 10.1038/bcj.2016.20 Full Text Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C R J Lin, T Moskovits, C S Diefenbach and K B Hymes Blood Cancer J 2016 6: e402; 10.1038/bcj.2016.16 Full Text Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120) X Papanikolaou, A Rosenthal, M Dhodapkar, J Epstein, R Khan, F van Rhee, Y Jethava, S Waheed, M Zangari, A Hoering, J Crowley, D Alapat, F Davies, G Morgan and B Barlogie Blood Cancer J 2016 6: e410; 10.1038/bcj.2016.19 Full Text Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma L Ratner, D Rauch, H Abel, B Caruso, A Noy, S K Barta, S Parekh, J C Ramos, R Ambinder, A Phillips, J Harding, H H Baydoun, X Cheng and S Jacobson Blood Cancer J 2016 6: e408; 10.1038/bcj.2016.21 Full Text Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis A Tefferi, A Al-Kali, K H Begna, M M Patnaik, T L Lasho, A Rizo, Y Wan and C A Hanson Blood Cancer J 2016 6: e405; 10.1038/bcj.2016.13 Full Text Corrigendum Top Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199) D C Phillips, Y Xiao, L T Lam, E Litvinovich, L Roberts-Rapp, A J Souers and J D Leverson Blood Cancer J 2016 6: e403; 10.1038/bcj.2016.12 Full Text You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.